Showing results (281-290 of 6,291) with videos related to

Sort By:
Pageof 630
Open Forum Infectious Diseases|August 4, 2023
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP)Alexy Inciarte, Ainoa Ugarte, María Martínez-Rebollar, et al.
Open Forum Infectious Diseases|August 3, 2023
Clinical Risk Scores to Predict Nonsusceptibility to Trimethoprim-Sulfamethoxazole, Fluoroquinolone, Nitrofurantoin, and Third-Generation Cephalosporin Among Adult Outpatient Episodes of Complicated Urinary Tract InfectionThomas P Lodise, Lie Hong Chen, Rong Wei, et al.
Open Forum Infectious Diseases|August 4, 2023
Humoral and Cellular Immune Responses of People Living With Human Immunodeficiency Virus After 3 Doses of Messenger RNA BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine: A Prospective Cohort StudyLuba Tau, David Hagin, Tal Freund, et al.
Open Forum Infectious Diseases|August 7, 2023
Increased Incidence and Risk of Septicemia and Urinary Tract Infection After Clostridioides difficile InfectionMargaret A Olsen, Matthew R Keller, Dustin Stwalley, et al.
Open Forum Infectious Diseases|August 4, 2023
Relapsing Babesiosis With Molecular Evidence of Resistance to Certain Antimicrobials Commonly Used to Treat Babesia microti InfectionsLuis A Marcos, Gary P Wormser
Open Forum Infectious Diseases|August 24, 2023
Renal Safety of Long-term Tenofovir Disoproxil Fumarate Treatment in Patients With Chronic Hepatitis BGezahegn M Woldemedihn, Hanna Aberra, Hailemichael Desalegn, et al.
Open Forum Infectious Diseases|August 24, 2023
Correction to: Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections
Open Forum Infectious Diseases|August 24, 2023
Correction to: Performance of Blood-Based Nucleocapsid Antigen Tests for Diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Infectious Viral Shedding: A Systematic Review
Open Forum Infectious Diseases|August 21, 2023
Additional Burden Averted in the United States From Use of MF59-Adjuvanted Seasonal Influenza Vaccine Compared With Standard Seasonal Influenza Vaccine Among Adults ≥65 YearsIan McGovern, Aditya Sardesai, Alexandra Taylor, et al.
Open Forum Infectious Diseases|August 18, 2023
Harm Reduction: A Missing Piece to the Holistic Care of Patients Who Inject DrugsNathanial S Nolan, Sarah M Fracasso Francis, Laura R Marks, et al.
Pageof 630